000			01588 a2200481 4500
005			20250513231946.0
264		0	_c20010215
008			200102s 0 0 eng d
022			_a0284-186X
024	7		_a10.1080/02841860050215927 _2doi
040			_aNLM _beng _cNLM
100	1		_aHeiskanen, T E
245	0	0	_aMorphine or oxycodone in cancer pain? _h[electronic resource]
260			_bActa oncologica (Stockholm, Sweden) _c2000
300			_a941-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalgesics, Opioid _xblood
650	0	4	_aCross-Over Studies
650	0	4	_aCytochrome P-450 CYP2D6 _xmetabolism
650	0	4	_aDebrisoquin _xmetabolism
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMorphinans _xblood
650	0	4	_aMorphine _xblood
650	0	4	_aMorphine Derivatives _xblood
650	0	4	_aNeoplasms _xblood
650	0	4	_aOxycodone _xblood
650	0	4	_aPain _xdrug therapy
650	0	4	_aPain Measurement _xdrug effects
650	0	4	_aPhenotype
700	1		_aRuismäki, P M
700	1		_aSeppälä, T A
700	1		_aKalso, E A
773	0		_tActa oncologica (Stockholm, Sweden) _gvol. 39 _gno. 8 _gp. 941-7
856	4	0	_uhttps://doi.org/10.1080/02841860050215927 _zAvailable from publisher's website
999			_c11144994 _d11144994